NDC 47682-808-99 - Mountain Series Weekender Medical
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 47682-808
- Requested NDC
- 47682-808-99
- Package NDCs from labels
- 47682-808-99
- Manufacturer
- Tender Corporation dba Adventure Medical Kits
- Effective date
- 2011-08-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Antiseptic Towelette - Tender Corporation dba Adventure Medical Kits | Tender Corporation dba Adventure Medical Kits | 2011-08-01 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 47682-808-99 | Mountain Series Weekender Medical | 2 in 1 PACKET | TABLET, FILM COATED | 2 | 200 mg | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 47682-808 | MOUNTAIN SERIES WEEKENDER MEDICAL (BENZALKONIUM CHLORIDE, POVIDONE-IODINE, ACETAMINOPHEN, ASPIRIN, DIPHENHYDRAMINE HYDROCHLORIDE, IBUPROFEN, BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE) KIT [TENDER CORPORATION DBA ADVENTURE MEDICAL KITS] | 1 | Unmatched | 20110801_e4b05cbc-526e-4a03-a943-631a0feb6947.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 47682-808-13 | EA - Each | 47682-808 | 0f9bb74d-9e95-402b-b680-33dfc130fe88 | 1 | 2012-07-24 |
| 47682-808-30 | EA - Each | 47682-808 | 7a51b6b0-cc50-4923-b5db-b246a975188a | 1 | 2015-10-02 |
| 47682-808-33 | EA - Each | 47682-808 | 40cc5d6b-7fc4-42f7-838c-1a401b8942e0 | 1 | 2012-07-24 |
| 47682-808-48 | EA - Each | 47682-808 | 5b1e19d4-e0e7-4437-a841-c419c32daa60 | 1 | 2013-03-03 |
| 47682-808-99 | EA - Each | 47682-808 | 3d91a842-9124-42ce-94b8-26aa91dd9d84 | 1 | 2018-03-08 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| American Safety and First Aid Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Orazen Inc | eb0d108f-42bf-3364-e053-2a95a90a4542 | 2026-09-07 | Warnings | 204602 89Y4M234ES 057Y626693 19371312D4 |
| Drx Choice childrens allergy chews | DIPHENHYDRAMINE HCL | RARITAN PHARMACEUTICALS INC | dd2be906-bd0a-437c-9693-54b9391a5da3 | 2026-09-05 | Warnings | TC2D6JAD40 |
| MEDI-FIRST | BENZALKONIUM CHLORIDE, LIDOCAINE | Orazen Inc | f508434f-5948-7134-e053-2a95a90a03d7 | 2026-09-05 | Warnings | F5UM2KM3W7 |
| MEDI-FIRST | BENZALKONIUM CHLORIDE, LIDOCAINE | Orazen Inc | f522fb0b-3d86-b228-e053-2a95a90a55e9 | 2026-09-05 | Warnings | F5UM2KM3W7 |
| DESENFRIOL-ITO PLUS | ACETAMINOPHEN | OPMX LLC | 5ac41edd-e845-734d-e063-6294a90a990a | 2026-09-05 | Warnings | M013 362O9ITL9D |
| DRX CHOICE Regular Strength | ACETAMINOPHEN | Raritan Pharmaceuticals Inc. | 8bacb24a-24d0-4175-b3e0-05efb5f5d373 | 2026-09-05 | Warnings | M013 313782 362O9ITL9D |
| Severe Congestion and Pain | ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL | Meijer Distribution, Inc. | 49235f4f-e661-4a83-88ef-b9a956848777 | 2026-09-04 | Warnings | 362O9ITL9D |
| NIGHTTIME COLD AND FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | Amazon.com Services LLC | 774d2bde-9f57-4ced-800a-cada39c685ed | 2026-09-04 | Warnings | 362O9ITL9D |
| IBUPROFEN | IBUPROFEN | Amazon.com Services LLC | 90659e83-d989-46a5-9680-3a4f61612511 | 2026-09-04 | Warnings | 310965 WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Direct_Rx | 40071818-5bf0-095b-e063-6294a90ad58a | 2026-09-04 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| MEDI-FIRST | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Orazen Inc | f4e4d0a4-b90c-99b0-e053-2995a90ab423 | 2026-09-04 | Warnings | 204602 89Y4M234ES 057Y626693 19371312D4 |
| Psoriasis Control | CENTELLA ASIATICA, SODIUM CHLORIDE, AND SILICON DIOXIDE | Forces of Nature | 2db33771-0bb9-49f8-84fa-dddc28e4ba26 | 2026-09-04 | Warnings | ETJ7Z6XBU4 |
| Lil Drug Store Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | ORAZEN INC | e6e5263b-328f-4775-9fac-34302f050ce0 | 2026-09-04 | Warnings | 204602 89Y4M234ES 057Y626693 19371312D4 |
| MEDI-FIRST | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Orazen Inc | f4e42c5c-e080-4efb-e053-2a95a90af52e | 2026-09-04 | Warnings | 204602 89Y4M234ES 057Y626693 19371312D4 |
| MEDI-FIRST | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Orazen Inc | f4e4854a-ee01-df72-e053-2995a90aa8ea | 2026-09-04 | Warnings | 204602 89Y4M234ES 057Y626693 19371312D4 |
| FRESHKOTE PRESERVATIVE FREE LUBRICANT EYE DROPS | POVIDONE, POLYVINYL ALCOHOL SOLUTION | Harrow Eye, LLC | 049e9cc9-0663-53bc-e063-6294a90a2c4f | 2026-09-04 | Warnings | FZ989GH94E |
| Circle K Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | ORAZEN INC | 84c3f7e4-b28b-40bb-8d9d-7c8d679e3a3a | 2026-09-04 | Warnings | 204602 89Y4M234ES 057Y626693 19371312D4 |
| Butalbital, Acetaminophen, Caffeine | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE | REMEDYREPACK INC. | dc2bb7fc-1722-4865-a02c-be5e5c211505 | 2026-09-03 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Feverall Jr. Strength | ACETAMINOPHEN | Sun Pharmaceutical Industries, Inc. | 3561bbc3-53b0-4857-8b71-39e165ed95ce | 2026-09-03 | Warnings | 362O9ITL9D |
| First Aid Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B, PRAMOXINE HCL | Walgreen Company | b982091a-5aa0-4bbc-bb1d-08016f6d0a70 | 2026-09-03 | Warnings | 89Y4M234ES 057Y626693 19371312D4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.